Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene—a gene that can cause cancer—that may ...

Revolution Medicines has partnered Royalty Pharma for $2bn in flexible funding to support the independent worldwide ...

Researchers have identified a mutation in a common oncogene that may play an important role in colon cancer. Their findings ...

Through the program, gene therapies are developed to treat patients with retinitis pigmentosa caused by pathogenic variants ...

A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct ...

Background Chronic inflammation and elevated reactive oxygen species are key contributors to hepatocellular carcinoma (HCC) ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing gene therapies for the ...

A new study from the University of Michigan Rogel Health Cancer Center, published in Science, sheds light on how two distinct ...

Researchers found that clinically achievable doses of curcumin, the active compound in turmeric, target and suppress ...

Scientists at Fox Chase Cancer Center have identified a mutation in a common oncogene — a gene that can cause cancer — that may play an important role ...

A new study led by researchers from the Institute of Zoology of the Chinese Academy of Sciences, along with their ...